Arrowhead Pharmaceuticals Inc (ARWR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Arrowhead Pharmaceuticals Inc (ARWR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3456
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arrowhead Pharmaceuticals Inc (Arrowhead), formerly Arrowhead Research Corp, is a pharmaceutical company that develops and markets medicinal products. The company develops pipeline drugs that are being developed to treat chronic hepatitis B virus infection for the treatment of liver disease, thrombosis and angioedema, cardiovascular disease and clear cell and renal cell carcinoma, among others. It offers design of internal preclinical and clinical development programs to enable novel new therapies. Arrowhead develops pipeline products such as ARO-AAT, ARO-HBV, ARO-APOC3, ARO-ANG3, ARO-ENaC, ARO-HIF2, AMG 890 and ARO-AMG1. The company has operations in California and Wisconsin. Arrowhead is headquartered in Pasadena, California, the US.

Arrowhead Pharmaceuticals Inc (ARWR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Arrowhead Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Arrowhead Research Acquires RNAi R&D Portfolio from Novartis for USD35 Million 13
Partnerships 15
Arrowhead Pharma Partners with Spring Bank Pharma 15
Arrowhead Research Enters Into Agreement With Shire To Develop Peptide-Targeted Therapeutics 16
Licensing Agreements 17
Amgen Enters into Licensing Agreement with Arrowhead Pharma 17
Alnylam Pharma Enters Into Licensing Agreement With Arrowhead Research 18
Arrowhead Research Enters Into Licensing Agreement With Alnylam Pharma 19
Equity Offering 20
Arrowhead Pharma Raises USD60.4 Million in Public Offering of Shares 20
Arrowhead Pharma to Raise Funds through Public Offering of Shares 22
Arrowhead Pharma Raises USD45 Million in Private Placement of Shares 23
Arrowhead Research Completes Public Offering Of Shares For US$120 Million 25
Arrowhead Research Completes Private Placement Of Shares For US$18 Million 26
Arrowhead Research Completes Private Placement Of Preferred Shares For US$46 Million 28
Arrowhead Research Completes Private Placement Of Shares For US$26 Million 30
Arrowhead Research Completes Private Placement Of Preferred Shares For US$10 Million 32
Arrowhead Research Completes Public Offering Of Units For US$3.5 Million 34
Arrowhead Research Completes Public Offering Of Units For US$4.3 Million 35
Arrowhead Research Raises USD6.2 Million in Private Placement Of Units 36
Acquisition 37
Silence Therapeutics Acquires 8.4% in Arrowhead Pharma 37
Arrowhead Research Acquires Alvos Therapeutics 38
Arrowhead Pharmaceuticals Inc – Key Competitors 39
Arrowhead Pharmaceuticals Inc – Key Employees 40
Arrowhead Pharmaceuticals Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Financial Announcements 42
May 08, 2018: Arrowhead Pharmaceuticals Reports Fiscal 2018 Second Quarter Results 42
Feb 09, 2018: Arrowhead Pharmaceuticals Reports Fiscal 2018 First Quarter Results 43
Dec 12, 2017: Arrowhead Pharmaceuticals Reports Fiscal 2017 Year End Results 44
Feb 06, 2017: Arrowhead Reports Fiscal 2017 First Quarter Results 45
Corporate Communications 46
Dec 27, 2017: Arrowhead Pharmaceuticals Appoints William Waddill to Board of Directors 46
Clinical Trials 47
Oct 23, 2017: Arrowhead Presents Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease at Liver Meeting 2017 47
Oct 10, 2017: Arrowhead Pharmaceuticals to Present Preclinical Data on ARO-AAT at The Liver Meeting 48
Other Significant Developments 49
Aug 07, 2018: Arrowhead Pharmaceuticals reports fiscal 2018 third quarter results 49
May 03, 2017: Arrowhead Reports Fiscal 2017 Second Quarter Results 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Arrowhead Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Arrowhead Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Arrowhead Research Acquires RNAi R&D Portfolio from Novartis for USD35 Million 13
Arrowhead Pharma Partners with Spring Bank Pharma 15
Arrowhead Research Enters Into Agreement With Shire To Develop Peptide-Targeted Therapeutics 16
Amgen Enters into Licensing Agreement with Arrowhead Pharma 17
Alnylam Pharma Enters Into Licensing Agreement With Arrowhead Research 18
Arrowhead Research Enters Into Licensing Agreement With Alnylam Pharma 19
Arrowhead Pharma Raises USD60.4 Million in Public Offering of Shares 20
Arrowhead Pharma to Raise Funds through Public Offering of Shares 22
Arrowhead Pharma Raises USD45 Million in Private Placement of Shares 23
Arrowhead Research Completes Public Offering Of Shares For US$120 Million 25
Arrowhead Research Completes Private Placement Of Shares For US$18 Million 26
Arrowhead Research Completes Private Placement Of Preferred Shares For US$46 Million 28
Arrowhead Research Completes Private Placement Of Shares For US$26 Million 30
Arrowhead Research Completes Private Placement Of Preferred Shares For US$10 Million 32
Arrowhead Research Completes Public Offering Of Units For US$3.5 Million 34
Arrowhead Research Completes Public Offering Of Units For US$4.3 Million 35
Arrowhead Research Raises USD6.2 Million in Private Placement Of Units 36
Silence Therapeutics Acquires 8.4% in Arrowhead Pharma 37
Arrowhead Research Acquires Alvos Therapeutics 38
Arrowhead Pharmaceuticals Inc, Key Competitors 39
Arrowhead Pharmaceuticals Inc, Key Employees 40
Arrowhead Pharmaceuticals Inc, Other Locations 41
Arrowhead Pharmaceuticals Inc, Subsidiaries 41

List of Figures
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Arrowhead Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Arrowhead Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Arrowhead Pharmaceuticals Inc (ARWR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cowen Inc:企業の戦略・SWOT・財務情報
    Cowen Inc - Strategy, SWOT and Corporate Finance Report Summary Cowen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Thomas Cook Group plc:企業の戦略・SWOT・財務情報
    Thomas Cook Group plc - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Parkway Properties Inc:企業のM&A・事業提携・投資動向
    Parkway Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Parkway Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • GREE, Inc. (3632):企業の財務・戦略的SWOT分析
    GREE, Inc. (3632) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Motif Bio Plc (MTFB):製薬・医療:M&Aディール及び事業提携情報
    Summary Motif Bio Plc (Motif Bio), formerly Motif Bio Ltd, is a clinical-stage biopharmaceutical company that focuses on the development of novel antibiotics to treat patients with infections caused by multi-drug resistant bacteria. The company develops Iclaprim, a targeted Gram-positive1 antibiotic …
  • Finnair Oyj:戦略・SWOT・企業財務分析
    Finnair Oyj - Strategy, SWOT and Corporate Finance Report Summary Finnair Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Becton, Dickinson:企業のM&A・事業提携・投資動向
    Becton, Dickinson - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Becton, Dickinson Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Nippon Paint (China) Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Snowy Hydro Ltd-エネルギー分野:企業M&A・提携分析
    Summary Snowy Hydro Limited (Snowy Hydro) is an integrated energy utility that generates, supplies, trades, and retails electricity. The company produces power from gas and hydro sources. It owns and operates gas plants: Valley Power, Laverton North, and Colongra; and Snowy Mountains Scheme hydroele …
  • TransMontaigne Partners LP (TLP):企業の財務・戦略的SWOT分析
    Summary TransMontaigne Partners LP (TLP), a subsidiary of TransMontaigne GP LLC is an energy infrastructure service provider that offers integrated terminaling, transportation, and storage services. The company distributes and transports crude oil, chemicals, petroleum products, fertilizers, and oth …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ramaco Resources Inc. (METC):企業の財務・戦略的SWOT分析
    Ramaco Resources Inc. (METC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cracker Barrel Old Country Store, Inc.:企業の戦略・SWOT・財務分析
    Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務情報
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Datwyler Holding Inc (DAE):企業の財務・戦略的SWOT分析
    Datwyler Holding Inc (DAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • 3i Group Plc:企業の戦略・SWOT・財務情報
    3i Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3i Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Luxair S.A.:企業の戦略・SWOT・財務情報
    Luxair S.A. - Strategy, SWOT and Corporate Finance Report Summary Luxair S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Reinhart FoodService L.L.C.:企業の戦略・SWOT・財務分析
    Reinhart FoodService L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Reinhart FoodService L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Meredith Corporation (MDP):企業の財務・戦略的SWOT分析
    Meredith Corporation (MDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆